EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis

Sara Deleu iD, Inge Jacobs, Jorge F Vazquez Castellanos, Sare Verstockt iD, Bruna Trindade de Carvalho, Ana Subotić, Bram Verstockt iD, Kaline Arnauts iD, Lowie Deprez, Eva Vissers iD, Matthias Lenfant iD, Greet Vandermeulen und 7 weitere

Nutrients · 2024

DOI: 10.3390/nu16162668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Sara Deleu und 18 weiteren Autor:innen. Beteiligte Einrichtung: TARGID, Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, 3000 Leuven, Belgium. Hauptthemen laut MEDLINE: Dextran Sulfate, Acetates, Saccharomyces cerevisiae, Colitis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grand Challenges Program of VIB, FWO, KU Leuven Internal Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acetate-producing Saccharomyces cerevisiae var. boulardii strains could exert improved effects on ulcerative colitis, which here, was preclinically evaluated in an acute dextran sodium sulphate induced model of colitis. Nine-week-old female mice were divided into 12 groups, receiving either drinking water or 2.75% dextran sodium sulphate for 7 days, combined with a daily gavage of various treatments with different levels of acetate accumulation: sham control (phosphate buffered saline, no acetate), non-probiotic control (Baker’s yeast, no acetate), probiotic control (Enterol®, transient acetate), and additionally several Saccharomyces cerevisiae var. boulardii strains with respectively no, high, and extra-high acetate accumulation. Disease activity was monitored daily, and feces samples were collected at different timepoints. On day 14, the mice were sacrificed, upon which blood and colonic tissue were collected for analysis. Disease activity in inflamed mice was lower when treated with the high-acetate-producing strain compared to sham and non-probiotic controls. The non-acetate-producing strain showed higher disease activity compared to the acetate-producing strains. Accordingly, higher histologic inflammation was observed in non- or transient-acetate-producing strains compared to the sham control, whereas this increase was not observed for high- and extra-high-acetate-producing strains upon induction of inflammation. These anti-inflammatory findings were confirmed by transcriptomic analysis of differentially expressed genes. Moreover, only the strain with the highest acetate production was superior in maintaining a stable gut microbial alpha-diversity upon inflammation. These findings support new possibilities for acetate-mediated management of inflammation in inflammatory bowel disease by administrating high-acetate-producing Saccharomyces cerevisae var. boulardii strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dextran SulfateAcetatesSaccharomyces cerevisiaeColitisProbioticsAnimalsFemaleMiceDisease Models, AnimalColonSaccharomyces boulardiiColitis, UlcerativeMutationGastrointestinal MicrobiomeFecesMice, Inbred C57BL

Stichwörter der Autor:innen

SCFASaccharomycesacetatemicrobiota modulationprobioticsulcerative colitis

Substanzen

Dextran SulfateAcetates

Autor:innen und Institutionen

  • TARGID, Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, 3000 Leuven, Belgium.
  • VIB-KU Leuven Center for Microbiology, 3001 Leuven, Belgium.
  • Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium.
  • NovelYeast bv, Bio-Incubator BIO4, Gaston Geenslaan 3, Leuven-Heverlee, 3001 Leuven, Belgium.
  • Department of Gastroenterology and Hepatology, UZ Leuven, KU Leuven, 3000 Leuven, Belgium.
  • Laboratory of Morphology and Molecular Pathology, UZ Leuven, 3000 Leuven, Belgium.

ORCID-Profile: Sara Deleu, Sare Verstockt, Bram Verstockt, Kaline Arnauts, Eva Vissers, Matthias Lenfant, Kristin Verbeke, Geert R B Huys, Johan M Thevelein, Séverine Vermeire

Förderung

  • Grand Challenges Program of VIB
  • FWO
  • KU Leuven Internal Funds
  • European Union’s Horizon Europe Research & Innovation programme
  • Clinical Research Fund KOOR

Zitieren

APA

Deleu, S., Jacobs, I., Vazquez Castellanos, J. F., Verstockt, S., Trindade de Carvalho, B., Subotić, A., Verstockt, B., Arnauts, K., Deprez, L., Vissers, E., Lenfant, M., Vandermeulen, G., De Hertogh, G., Verbeke, K., Matteoli, G., Huys, G. R. B., Thevelein, J. M., Raes, J., & Vermeire, S. (2024). Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis. Nutrients. https://doi.org/10.3390/nu16162668

Vancouver

Deleu S, Jacobs I, Vazquez Castellanos JF, Verstockt S, Trindade de Carvalho B, Subotić A, et al. Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis. Nutrients. 2024. doi:10.3390/nu16162668

BibTeX
@article{Deleu2024,
  author = {Deleu, Sara and Jacobs, Inge and Vazquez Castellanos, Jorge F and Verstockt, Sare and Trindade de Carvalho, Bruna and Subotić, Ana and Verstockt, Bram and Arnauts, Kaline and Deprez, Lowie and Vissers, Eva and Lenfant, Matthias and Vandermeulen, Greet and De Hertogh, Gert and Verbeke, Kristin and Matteoli, Gianluca and Huys, Geert R B and Thevelein, Johan M and Raes, Jeroen and Vermeire, Séverine},
  title = {Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16162668}
}
Kostenlos starten →